Laboratory monitoring for HIV disease in resource-limited settings has now become one of the key challenges for antiretroviral treatment (ART) access and success, as emphasized by the 2010 revised WHO ...
SANTA CLARA, Calif--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for ...
The rapid expansion of antiretroviral treatment (ART) programs in low- and middle-income countries in recent years has produced dramatic declines in mortality. Laboratory monitoring for HIV disease in ...
SANTA CLARA, Calif--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results